Pan-Cancer 6-Fusion Panel
Horizon's newest gene fusion panel containing 3 NTRK fusions plus ALK, RET and ROS
Gene fusions have been identified in almost all major cancer types
Many kinase fusions are actionable targets for cancer therapy with kinase inhibitors.
So, confident detection and identification of specific RNA fusions is vitally important.
Horizon's 100% cell line-derived RNA reference standards support robust quality control and workflow validation:
Horizon's newest gene fusion panel containing 3 NTRK fusions plus ALK, RET and ROS
Designed to compliment the Pan-Cancer 6-Fusion Panel, this reference standard is negative for RNA fusions
Horizon's custom designed reference standards can be manufactured specifically to your workflow requirements